Pulmonary fibrosis is a critical threat across ILDs
Interstitial lung diseases (ILDs) are a heterogeneous group of lung diseases that vary in etiology1–3
Learn more about the critical threat of pulmonary fibrosis in ILDs
See what Vincent Cottin, Professor of Respiratory Medicine, has to say about the importance of pulmonary fibrosis in IPF and in a range of non-IPF ILDs
6314387992112
Fibrosis is an excessive deposition of extracellular matrix within the lungs. Pulmonary fibrosis is actually characterised histologically, and pulmonary fibrosis occurs in a number of conditions, including idiopathic pulmonary fibrosis, which is most typical of these conditions characterised by progressive onset, but what we have learned in recent years is the importance also of pulmonary fibrosis in other conditions.
What we call pulmonary fibrosis may also occur in other conditions, for example, in connective tissue disease, scleroderma, rheumatoid arthritis with interstitial lung disease, and other connective tissue disease. In chronic HP, chronic hypersensitivity pneumonitis, which is related to exposure to an antigen, there are acute forms that are reversible, but there are also chronic forms that often include some fibrosis.
ILD patient cases
Ben has IPF
What signs and symptoms could turn out to be IPF?
Robert has cHP
Which signs and symptoms should prompt referral for suspected cHP?
Stephanie has SSc-ILD
How can you ensure an early referral and diagnosis for suspected SSc-ILD?
Julia has RA-ILD
How can you ensure an early referral and diagnosis for suspected RA-ILD?
Abbreviations
cHP, chronic hypersensitivity pneumonitis; CTD-ILD, connective tissue disease-associated interstitial lung disease; ILD, interstitial lung disease; IPF, idiopathic pulmonary fibrosis; RA-ILD, rheumatoid arthritis-associated interstitial lung disease; SSc-ILD, systemic sclerosis-associated interstitial lung disease.
- Cottin V, Hirani N, Hotchkin D, et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27(150):180076.
- Demedts M, Wells AU, Antó JM, et al. Interstitial lung diseases: an epidemiological overview. Eur Respir J. 2001;18(suppl 32):2s-16s.
- Ryu JH, Daniels CE, Hartman TE, Yi ES. Diagnosis of interstitial lung diseases. Mayo Clin Proc. 2007;82(8):976–986.
Resources for patients
